|
|
Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy |
Li Zhuo, Nianrong Zhang, Guming Zou, Dapeng Chen, Wenge Li() |
Department of Nephrology, China–Japan Friendship Hospital, Beijing 100029, China |
|
|
Abstract Kidney damage is common in patients with diabetes mellitus (DM). However, whether the type of kidney damage can be reliably diagnosed using clinical data alone remains unclear. Predictive factors for diabetic nephropathy (DN) outcomes are also poorly understood. In this study, the clinical manifestations of 111 cases of biopsy-proven DN were described, and the clinical and pathological parameters of patients with different DN outcomes were compared. Results showed that long DM duration (>10 years in 32.4% of patients), severe proteinuria (62.2%), and renal dysfunction (estimated glomerular filtration rate [eGFR]<60 mL/(min·1.73 m2)) (52.3%) did not accurately indicate whether the condition of these patients progressed to DN. Hematuria (48.6%) failed to specify either DN or nondiabetic renal disease. Diabetic retinopathy (78.4%) was a crucial complication in patients with DN. Kaplan–Meier analysis revealed that the renal survival of 53 patients who were diagnosed with DN and were followed up was not significantly associated with glomerular classification (P>0.05). Cox’s regression analysis demonstrated that renal survival time was significantly influenced by sex (b= 1.394, P= 0.038), hematuria (b= 0.036, P= 0.029), and eGFR (b= −0.039, P= 0.002) but was not significantly affected by age, 24 h urinary protein excretion, or glomerular classification (P>0.05). In conclusion, the clinical characteristics of DN vary, and renal biopsy is necessary to determine renal damage patterns. Sex, hematuria, and the eGFR may affect DN outcomes, whereas the glomerular classification may not.
|
Keywords
diabetic nephropathy
clinical characteristics
renal biopsy
outcomes
|
Corresponding Author(s):
Wenge Li
|
Just Accepted Date: 26 July 2017
Online First Date: 14 August 2017
Issue Date: 29 August 2017
|
|
19 |
MiseK, Hoshino J, UbaraY , SumidaK, Hiramatsu R, HasegawaE , YamanouchiM, HayamiN, SuwabeT, Sawa N, FujiiT , OhashiK, HaraS, TakaichiK. Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy.Nephrol Dial Transplant2014; 29(1): 109–118
https://doi.org/10.1093/ndt/gft349
pmid: 24151019
|
1 |
MarinoJS, Peterson SJ, LiM , VanellaL, SodhiK, HillJW, Abraham NG. ApoA-1 mimetic restores adiponectin expression and insulin sensitivity independent of changes in body weight in female obese mice.Nutr Diabetes2012; 2(3): e33
https://doi.org/10.1038/nutd.2012.4
pmid: 23169576
|
2 |
XuY, WangL, HeJ, BiY, LiM, WangT, WangL, Jiang Y, DaiM , LuJ, XuM, LiY, HuN, LiJ, MiS, ChenCS, Li G, MuY , ZhaoJ, KongL, ChenJ, Lai S, WangW , ZhaoW, NingG; 2010 China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults.JAMA2013; 310(9): 948–959
https://doi.org/10.1001/jama.2013.168118
pmid: 24002281
|
3 |
CollinsAJ, FoleyRN, HerzogC, Chavers B, GilbertsonD , IshaniA, Johansen K, KasiskeB , KutnerN, LiuJ, St PeterW, Ding S, GuoH , KatsA, LambK, LiS, Roberts T, SkeansM , SnyderJ, SolidC, ThompsonB, Weinhandl E, XiongH , YusufA, ZaunD, ArkoC, Chen SC, DanielsF , EbbenJ, Frazier E, HanzlikC , JohnsonR, SheetsD, WangX, Forrest B, ConstantiniE , EversonS, EggersP, AgodoaL. US Renal Data System 2012 Annual Data Report. Am J Kidney Dis2013; 61(1 Suppl 1): A7, e1–476
https://doi.org/10.1053/j.ajkd.2012.11.031
|
4 |
GrossJL, de Azevedo MJ, SilveiroSP , CananiLH, Caramori ML, ZelmanovitzT . Diabetic nephropathy: diagnosis, prevention, and treatment.Diabetes Care2005; 28(1): 164–176
https://doi.org/10.2337/diacare.28.1.164
pmid: 15616252
|
5 |
LinYL, PengSJ, FerngSH, Tzen CY, YangCS . Clinical indicators which necessitate renal biopsy in type 2 diabetes mellitus patients with renal disease.Int J Clin Pract2009; 63(8): 1167–1176
https://doi.org/10.1111/j.1742-1241.2008.01753.x
pmid: 18422591
|
6 |
KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis2007; 49(2 Suppl 2): S12–S154
https://doi.org/10.1053/j.ajkd.2006.12.005
pmid: 17276798
|
7 |
World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1, Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999
|
8 |
WilkinsonCP, FerrisFL 3rd, KleinRE , LeePP, AgardhCD, DavisM, Dills D, KampikA , PararajasegaramR, Verdaguer JT; Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.Ophthalmology2003; 110(9): 1677–1682
https://doi.org/10.1016/S0161-6420(03)00475-5
pmid: 13129861
|
9 |
WhitworthJA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension.J Hypertens2003; 21(11): 1983–1992
https://doi.org/10.1097/00004872-200311000-00002
pmid: 14597836
|
10 |
StevensLA, Claybon MA, SchmidCH , ChenJ, HorioM, ImaiE, Nelson RG, Van DeventerM , WangHY, ZuoL, ZhangYL, Levey AS. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities.Kidney Int2011; 79(5): 555–562
https://doi.org/10.1038/ki.2010.462
pmid: 21107446
|
11 |
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).Kidney Int Suppl2009; (113): S1–S130
pmid: 19644521
|
12 |
MogensenC. Early diabetic renal involvement and nephropathy. In: Alberti KGMM, Krall LP. The Diabtes Annual. Vol 3. Amsterdam: Elsevier Science publishers, 1987: 306
|
13 |
ZhuoL, RenW, LiW, ZouG, LuJ. Evaluation of renal biopsies in type 2 diabetic patients with kidney disease: a clinicopathological study of 216 cases.Int Urol Nephrol2013; 45(1): 173–179
https://doi.org/10.1007/s11255-012-0164-6
pmid: 22467137
|
14 |
ZhuoL, ZouG, LiW, LuJ, RenW. Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus.Eur J Med Res2013; 18(1): 4
https://doi.org/10.1186/2047-783X-18-4
pmid: 23432977
|
15 |
TervaertTW, Mooyaart AL, AmannK , CohenAH, CookHT, DrachenbergCB , FerrarioF, FogoAB, HaasM, de Heer E, JohK , NoëlLH, Radhakrishnan J, SeshanSV , BajemaIM, BruijnJA; Renal Pathology Society. Pathologic classification of diabetic nephropathy.J Am Soc Nephrol2010; 21(4): 556–563
https://doi.org/10.1681/ASN.2010010010
pmid: 20167701
|
16 |
JiaW. Obesity in China: its characteristics, diagnostic criteria, and implications.Front Med2015; 9(2): 129–133
https://doi.org/10.1007/s11684-015-0387-x
pmid: 25620117
|
17 |
AnY, XuF, LeW, GeY, ZhouM, Chen H, ZengC , ZhangH, LiuZ. Renal histologic changes and the outcome in patients with diabetic nephropathy.Nephrol Dial Transplant2015; 30(2): 257–266
https://doi.org/10.1093/ndt/gfu250
pmid: 25063425
|
18 |
HoshinoJ, MiseK, UenoT, Imafuku A, KawadaM , SumidaK, Hiramatsu R, HasegawaE , YamanouchiM, HayamiN, SuwabeT, Sawa N, HaraS , FujiiT, OhashiK, UbaraY, Takaichi K. A pathological scoring system to predict renal outcome in diabetic nephropathy.Am J Nephrol2015; 41(4-5): 337–344
https://doi.org/10.1159/000431333
pmid: 26067713
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|